Announcements
26 January 2025
Acknowledgment to the Reviewers of JCM in 2024
23 January 2025
Journal of Clinical Medicine | 2024 Most Downloaded Papers (I)
22 January 2025
Meet Us at the 102nd Annual Meeting for the Osaka Society for Dialysis Therapy, 2 March 2025, Osaka, Japan
21 January 2025
MDPI Open Science Insights: Academic Publishing Exchange at Chiang Mai University, Thailand, Held on 9 January 2025
Recently, MDPI successfully organized an academic exchange session at Chiang Mai University, a prestigious institution in Thailand renowned for its academic excellence. This event took place during the Agricultural Biomedical Research Conference at Chiang Mai University, further enhancing its significance and reach.
The academic publishing exchange, held on 9 January 2025, aimed to equip students with invaluable insights and practical skills related to medical journal publication. The session covered varied topics, including introductions to the medical journals of MDPI, English scientific paper writing, strategies for responding to reviewer comments, and explorations of the transformative applications of artificial intelligence in academic publishing.
At the beginning, Assoc. Prof. Dr. Teera Chewonarin, Head of the Biochemistry Department, at Chiang Mai University, expressed his heartfelt appreciation to MDPI Thailand for the invaluable contribution (MDPI Academic Publishing Exchange) to the International Symposium of the Agricultural Biomedical Research Network 2025. Their expertise in academic publishing, guidance on paper preparation, and comprehensive introduction to MDPI and its related journals have provided our audiences and students with essential tools for their academic and research endeavors. This collaboration underscores the importance of partnerships in fostering knowledge exchange and supporting the growth of the scientific community. In addition, Assoc. Prof. Dr. Chewonarin stated that he is confident that today’s insights will leave a lasting impact on all participants and inspire further excellence in research and publication.
In the first session, Dr. Juthathip Poofery, Group Leader of the Medical Science section at MDPI Thailand, shared valuable insights into the growing trend of open access publishing and the remarkable development of MDPI as the leading global open access publisher. She highlighted MDPI’s worldwide collaborations and provided detailed indexing information about its journals, including the top five MDPI journals in which Chiang Mai University and the Faculty of Medicine have published research. Dr. Poofery also presented an in-depth overview of the top three MDPI journals from the Faculty of Medicine — Foods, Journal of Clinical Medicine (JCM), International Journal of Molecular Sciences (IJMS) — covering their scope, Journal Citation Reports (JCRs), and CiteScore categories ranking. Furthermore, she emphasized notable institutional partnerships including the Institutional Open Access Program (IOAP) agreement between MDPI and Kasetsart University, as well as the National Open Access agreement between MDPI and ZB MED, a German research institution.
In the second session, MDPI’s Regional Journal Relations Specialist, Dr. Krit Inthajak, presented “How to Write Scientific Papers in English”. This session focused on how to prepare a manuscript before submitting it to the publishing house and how to draw attention from the readers and reviewers. Next, he discussed each of the main sections of the manuscript, including the front matter, the main text, and the back matter. He also highlighted areas in which the authors could prevent ethical issues during manuscript processing.
The third session, titled “How to Respond to Peer-Reviewers”, was presented by Ms. Hathaipat Kittirojana, a Regional Journal Relations Specialist. She discussed various aspects of the open-access publishing model and the review process at MDPI. During the session, she actively engaged with the audience, addressing their questions. Some participants inquired about how to effectively respond to contradictory reviewer comments, while others were curious about how MDPI ensures the quality of its peer-review process. She also offered practical advice for responding to reviewers and shared insights into the types of feedback authors may face during revisions. In conclusion, she encouraged the audience to remain positive, open-minded, and professional when replying to reviewers.
In the last part, the Academic Publishing Exchange program concluded with a session on “Artificial Intelligence (AI) in Scientific Publishing”, delivered by Ms. Ploy Assavajamroon, Regional Journal Relations Specialist. She began by providing an overview of AI technology, which is widely used nowadays, before delving into its capabilities and its impact on scientific publishing, highlighting both current advancements and challenges. In alignment with the Committee on Publication Ethics (COPE) position statement, the session thoroughly covered guidelines regarding AI, authorship, and the peer-review process. To wrap up, the AI tools developed by MDPI’s AI team were introduced, showcasing their potential to enhance processes and services for both internal and external users.
The event at Chiang Mai University received overwhelmingly positive feedback from participants, who appreciated the practical insights and networking opportunities provided. MDPI is grateful for the warm reception and support extended by Chiang Mai University and looks forward to future collaborations that further promote academic excellence and research dissemination. The success of this exchange underscores MDPI's commitment to supporting researchers at all stages of their careers and contributing to the global dissemination of scientific knowledge.
Please feel free to contact us at bangkok@mdpi.com if you would like to meet with MDPI in Thailand. We also anticipate continuing our collaboration with other leading educational institutions to empower the next generation of researchers and scholars.
21 January 2025
MDPI’s Newly Launched Journals in December 2024
Nine new journals covering multiple subjects launched their inaugural issues in December 2024. We are excited to be able to share with you the newest research rooted in the value of open access.
We would like to express our deepest appreciation to all of the Editorial Board Members, and each journal will ensure its high-quality output by using excellent editorial and rigorous peer-review processes, to ensure that the articles achieve high impact and visibility.
Please feel free to browse and discover more about the new journals below.
| Journal | Founding Editor-in-Chief | Journal Topics (Selected) |
|
|
Prof. Dr. Zhaoyang Dong |
energy storage technologies; energy storage system management; energy storage applications; strategies in renewable energy generation grid integration; distributed storage systems; economics and markets for energy storage View journal scope | Submit an article |
 |
Prof. Dr. Yang-Hui He 1. London Institute for Mathematical Sciences, Royal Institution, UK 2. University of Oxford, UK Editorial | View inaugural issue |
Euclidean geometry; differential geometry; algebraic geometry; complex geometry; discrete geometry; computational geometry; geometric group theory; convex geometry View journal scope | Submit an article |
 |
Dr. Michel Planat Université de Franche-Comté, France Editorial | View inaugural issue |
differential topology; algebraic topology; manifold topology; homology theory; low-dimensional topology; fuzzy sets View journal scope | Submit an article |
 |
Prof. Dr. Rashid Al Abri 1. Sultan Qaboos University, Oman 2. Oman Medical Association, Oman Editorial | View inaugural issue |
clinical practices as well as research and innovation in medical education, risk management in healthcare, and patient safety View journal scope | Submit an article |
 |
Prof. Dr. Ecevit Bilgili* New Jersey Institute of Technology, USA *Prof. Dr. Ecevit Bilgili passed away before the completion of the inaugural issue. His dedication and vision for JPBI will always be remembered and serve as a guiding inspiration. Editorial | View inaugural issue |
early drug discovery and development; product characterization and pre-clinical testing; drug delivery systems and drug design; active pharmaceutical ingredient (API) production View journal scope | Submit an article |
 |
Dr. Weiyong Liu Huazhong University of Science and Technology, China Editorial | View inaugural issue |
theories, methodologies, technologies, and applications in the fields of laboratory medicine and clinical chemistry View journal scope | Submit an article |
 |
Prof. Dr. Manuel Pedro Rodríguez Bolívar University of Granada, Spain Editorial | View inaugural issue |
scientometrics; informetrics; bibliometrics; altmetrics; webometrics; research evaluation View journal scope | Submit an article |
 |
Prof. Dr. Fei Fan Wuhan University, Wuhan 430072, China Editorial | View inaugural issue |
regional growth theory and methods; regional system modeling and optimization; regional development policy; regional spatial evolution; environmental policy and instrument choice View journal scope | Submit an article |
 |
Dr. Kevin Cianfaglione Université Catholique de Lille, France Editorial | View inaugural issue |
wild species and their habitats; wild environments and biodiversity; natural environment management; wild land preservation View journal scope | Submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here, or contact the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.
16 January 2025
Journal of Clinical Medicine | Issue Cover Articles in 2024 (I)
Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is a semimonthly journal published online by MDPI. Manuscripts are peer-reviewed, and a first decision is provided to authors approximately 16 days after submission; acceptance to publication is undertaken in 2.6 days (median values for papers published in this journal in the second half of 2024). In 2024, we managed to publish 7808 articles. We sincerely thank the members of our Editorial Board and our reviewers, whose meticulous review and rigorous quality control processes ensure the exceptional quality of our publications. Additionally, we wish to thank all our contributing scholars for choosing us to publish their excellent research. The Editorial Office has selected 24 articles to be Issue Cover Articles. These selected works span a wide range of fields within the journal's scope and are intended to provide valuable insights and reliable references for scholars in related disciplines. Let us jointly review part of these excellent articles.
To access more information about all the articles, please visit the following: link: https://www.mdpi.com/search?q=&journal=jcm&sort=pubdate&page_count=50.
 |
1. “Treatment of Refractory Cardiac Arrest by Controlled Reperfusion of the Whole Body: A Multicenter, Prospective Observational Study” by Georg Trummer, Christoph Benk, Jan-Steffen Pooth, Tobias Wengenmayer, Alexander Supady, Dawid L. Staudacher, Domagoj Damjanovic, Dirk Lunz, Clemens Wiest, Hug Aubin et al. J. Clin. Med. 2024, 13(1), 56; https://doi.org/10.3390/jcm13010056 Available online: https://www.mdpi.com/2077-0383/13/1/56 |
 |
2. “Chronic Kidney Disease in the Older Adult Patient with Diabetes” by Raja Ravender, Maria-Eleni Roumelioti, Darren W. Schmidt, Mark L. Unruh and Christos Argyropoulos J. Clin. Med. 2024, 13(2), 348; https://doi.org/10.3390/jcm13020348 Available online: https://www.mdpi.com/2077-0383/13/2/348 |
 |
3. “Recent Advances and Future Directions in Syncope Management: A Comprehensive Narrative Review” by Anna Maria Martone, Iris Parrini, Francesca Ciciarello, Vincenzo Galluzzo, Stefano Cacciatore, Claudia Massaro, Rossella Giordano, Tommaso Giani, Giovanni Landi, Michele Massimo Gulizia et al. J. Clin. Med. 2024, 13(3), 727; https://doi.org/10.3390/jcm13030727 Available online: https://www.mdpi.com/2077-0383/13/3/727 |
 |
4. “Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients” by Chinmay Bera, Nashla Hamdan-Perez and Keyur Patel J. Clin. Med. 2024, 13(4), 1046; https://doi.org/10.3390/jcm13041046 Available online: https://www.mdpi.com/2077-0383/13/4/1046 |
 |
5. “Validation of SeptiCyte RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation” by Robert Balk, Annette M. Esper, Greg S. Martin, Russell R. Miller, III, Bert K. Lopansri, John P. Burke, Mitchell Levy, Steven Opal, Richard E. Rothman, Franco R. D’Alessio et al. J. Clin. Med. 2024, 13(5), 1194; https://doi.org/10.3390/jcm13051194 Available online: https://www.mdpi.com/2077-0383/13/5/1194 |
 |
6. “Candida auris Infection, a Rapidly Emerging Threat in the Neonatal Intensive Care Units: A Systematic Review” by Rozeta Sokou, Alexia Eleftheria Palioura, Paschalia Kopanou Taliaka, Aikaterini Konstantinidi, Andreas G. Tsantes, Daniele Piovani, Konstantina A. Tsante, Eleni A. Gounari, Zoi Iliodromiti, Theodora Boutsikou et al. J. Clin. Med. 2024, 13(6), 1586; https://doi.org/10.3390/jcm13061586 Available online: https://www.mdpi.com/2077-0383/13/6/1586 |
 |
7. “Innovations to Improve Lung Isolation Training for Thoracic Anesthesia: A Narrative Review” by Corinne Grandjean, Gabriele Casso, Leslie Noirez, Manuel Granell Gil, Georges L. Savoldelli and Patrick Schoettker J. Clin. Med. 2024, 13(7), 1848; https://doi.org/10.3390/jcm13071848 Available online: https://www.mdpi.com/2077-0383/13/7/1848 |
 |
8. “Sexual Dysfunction in Postural Orthostatic Tachycardia Syndrome (POTS): A Cross-Sectional, Case-Control Study” by Svetlana Blitshteyn, Anna Lange, Chelsea Corinaldi, Paige Guy and Jill Brook J. Clin. Med. 2024, 13(8), 2274; https://doi.org/10.3390/jcm13082274 Available online: https://www.mdpi.com/2077-0383/13/8/2274 |
 |
9. “Treatment of Acute Kidney Injury: A Review of Current Approaches and Emerging Innovations” by Christina Tamargo, Mohamad Hanouneh and C. Elena Cervantes J. Clin. Med. 2024, 13(9), 2455; https://doi.org/10.3390/jcm13092455 Available online: https://www.mdpi.com/2077-0383/13/9/2455 |
 |
10. “Multi-Modal Prehabilitation in Thoracic Surgery: From Basic Concepts to Practical Modalities” by Marc Licker, Diae El Manser, Eline Bonnardel, Sylvain Massias, Islem Mohamed Soualhi, Charlotte Saint-Leger and Adrien Koeltz J. Clin. Med. 2024, 13(10), 2765; https://doi.org/10.3390/jcm13102765 Available online: https://www.mdpi.com/2077-0383/13/10/2765 |
 |
11. “Mechanical Circulatory Support Devices in Patients with High-Risk Pulmonary Embolism” by Rama Ellauzi, Saliha Erdem, Mohammad Fahad Salam, Ashish Kumar, Vikas Aggarwal, Gerald Koenig, Herbert D. Aronow and Mir Babar Basir J. Clin. Med. 2024, 13(11), 3161; https://doi.org/10.3390/jcm13113161 Available online: https://www.mdpi.com/2077-0383/13/11/3161 |
 |
12. “Ophthalmic Complications, Diagnosis, and Treatment of Congenital Human Cytomegalovirus Infection” by Monika Modrzejewska, Piotr Połubiński and Oliwia Zdanowska J. Clin. Med. 2024, 13(12), 3379; https://doi.org/10.3390/jcm13123379 Available online: https://www.mdpi.com/2077-0383/13/12/3379 |
10 January 2025
Journal of Clinical Medicine | 2024 Editorial Board Meeting of the Section “Obstetrics and Gynecology”
9 January 2025
JCM Webinar | Glomerular Diseases Pathophysiology and Treatment, 20 January 2025
This webinar will review the state of the art in the pathophysiology and management of three important glomerular diseases: IgA nephropathy, the most frequent primary glomerular disease worldwide; membranous nephropathy, the paradigm of autoimmune glomerular diseases; and lupus nephritis, the most severe complication of systemic lupus erythematosus.
Each of these diseases will be discussed by an eminent expert in the field, namely Prof. Rosanna Coppo for IgA nephropathy, Prof. Lucia Del Vecchio for membranous nephropathy, and Prof. Gabriella Moroni for lupus nephritis. In their comprehensive yet concise presentations, the speakers will provide not only an evidence-based review of the topic but also practical recommendations to guide the day-to-day management of individual patients. Every talk will be followed by questions from the audience and answers from the speakers. The discussion will be managed by the chairs.
The main goal of this webinar is to provide practical information organized in an understandable manner. We are confident that our invited experts will be able to achieve this goal.
Date: 20 January 2025
Time: 4:00 p.m. CET | 10:00 a.m. EST | 11:00 p.m. CST Asia
Webinar ID: 831 9896 4221
Webinar Secretariat: journal.webinar@mdpi.com
Webinar announcement: https://sciforum.net/event/JCM-13
Register now for free!
|
Speaker/Presentation |
Time in CEST/CET (Basel time) |
Time in EST |
|
Prof. Dr. Francesco Locatelli and Prof Dr. Claudio Ponticelli |
4:00–4:10 p.m. |
10:00–10:10 a.m. |
|
Prof. Rosanna Coppo |
4:10–4:30 p.m. |
10:10–10:30 a.m. |
|
Prof. Lucia Del Vecchio |
4:30–4:50 p.m. |
10:30–10:50 a.m. |
|
Prof. Gabriella Moroni |
4:50–5:10 p.m. |
10:50–11:10 a.m. |
|
Q&A Session |
5:10–5:25 p.m. |
11:10–11:25 a.m. |
|
Prof. Dr. Francesco Locatelli and Prof. Dr. Claudio Ponticelli |
5:25–5:30 p.m. |
11:25–11:30 a.m. |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic or institutional email addresses will be prioritized.
Unable to attend? Feel free to still register; we will inform you when the recording is available.
Webinar Chair and Keynote Speakers:
- Prof. Dr. Francesco Locatelli, Department of Nephrology and Dialysis, Alessando Manzoni Hospital, Lecco, Italy;
- Prof. Dr. Claudio Ponticelli, Director Nephrology Division, Ospedale Maggiore, Milan, Italy;
- Prof. Rosanna Coppo, Freelance nephrologist. Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy;
- Prof. Lucia Del Vecchio, Department of Nephrology and Dialysis, ASST Lariana, Como, Italy;
- Prof. Gabriella Moroni, 1Department of Biomedical Sciences, Humanitas University, Milan, Italy; 2Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Milan, Italy.
Relevant Special Issue:
“Novelties in the Treatment of Glomerulonephritis”
Guest Editor: Prof. Dr. Francesco Locatelli
Deadline for manuscript submissions: 30 April 2025
7 January 2025
MDPI INSIGHTS: The CEO's Letter #19 - Reflecting on 2024, Society Journals, OA Germany
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Reflecting on 2024: Celebrating Our Progress and People
As we reflect on the year gone by, I’m proud and thankful for what we’ve accomplished together. This has been a year of growth, learning, and resilience, all of which have shaped MDPI’s journey. I would like to thank each of our employees for their dedication, hard work, and commitment to advancing open access (OA) publishing.
Our growth is evident: from about 5,900 colleagues at the end of 2023 to over 6,650 today, our global MDPI community continues to expand. We expanded our global operations with a new office in Seoul, South Korea, and celebrated a record-breaking year with 60 MDPI journals newly indexed in the Web of Science and 37 MDPI journals accepted into Scopus. As at 30 December, 2024, we publish 457 journals, of which 448 are peer-reviewed and 9 dedicated to academic conference outputs. Of these, 306 are indexed in Scopus, 298 in the Web of Science, and 90 in PubMed.
Looking for a new role in 2025? We have a variety of roles currently open!
Yet, growth never comes without its challenges. This year, we faced setbacks, including the removal of the Journal of Personalized Medicine from the Web of Science due to content relevance concerns. Our editorial and research integrity teams are actively addressing these issues, and we aim to reapply for indexation in December 2026. On another front, the decision by JUFO, The Finnish Publication Forum, to downgrade many MDPI journals presented a challenge. However, we are engaging with the Finnish research community and our editorial boards to provide scientific data supporting a reevaluation of MDPI journals in alignment with Finland’s national open access policies.
These examples remind us that challenges are part of our journey. What defines us is how we respond, by learning, adapting, and improving our practices and operations.
On the partnerships front, we achieved a landmark national open access agreement with over 100 German universities, effective 1 January 2025, bringing our total of Institutional Open Access Program (IOAP) partners to over 950. These achievements reflect not just our ambition but also the trust placed in MDPI by our collaborators worldwide.
Amidst growth and change, one constant remains: the people of MDPI. This year, I had the privilege of representing MDPI at important meetings and conferences from Beijing to Krakow, while visiting many of our offices, from Tokyo and Cluj to Manchester and Toronto. The highlight of my year has been meeting and connecting with so many of you.
“MDPI thrives because of community and collaboration”
When asked what makes MDPI a great place to work, my answer is simple: It’s the people. Our authors frequently praise the support and professionalism of our editorial staff. That same care extends inward, reflected in the friendships and collaborations we regularly nurture with our colleagues. MDPI thrives because of the community and collaboration that drives us forward.
As the African proverb states, “If you want to go fast, go alone. If you want to go far, go together.” I believe MDPI embodies both, being speedy in our daily operations and united in our purpose of promoting open access publishing.
Looking ahead to 2025, let us continue building a culture of care and support for one another, take pride in our work, and strive to improve all that we do. Thank you for making 2024 a special year, and I look forward to what we can achieve together in 2025.
PS: I look forward to sharing more about our people and the achievements of the past year in the 2024 Annual Report.
Impactful Research
685 MDPI Editors Named Highly Cited Researchers in 2024
I’m excited to celebrate the achievements of 685 Editorial Board Members (EBMs) from our journals, representing 39 countries and territories, who have been named Highly Cited Researchers for 2024 by Clarivate. This prestigious recognition highlights their scientific contributions, which transcend academic boundaries to drive progress in global knowledge, sustainability, security, and well-being.
Here, you’ll find the list of MDPI’s EBMs who have been recognized this year.
Clarivate’s annual Highly Cited Researcher™ list identifies the most influential scientists of the past decade – those whose work has made a profound and far-reaching impact across numerous scientific and social science disciplines. To be included on this list is no small feat. These researchers’ impactful papers rank among the top 1% by citations in one or more of the 21 fields analyzed within the “Essential Science Indicators,” positioning them as leaders in their domains.
As Clarivate notes, “Highly Cited Researchers have demonstrated significant and broad influence in their field(s) of research.” In 2024, a total of 6,886 Highly Cited Researcher designations were awarded to 6,636 individuals globally.
I extend my congratulations to all of MDPI’s EBMs who have achieved this milestone. Their dedication and excellence inspire us all and exemplify the high standards we uphold as a publisher. Congratulations to each of them for this incredible accomplishment and for their ongoing contributions to advancing knowledge in their fields.
Inside MDPI
How MDPI / Open Access Supports Societies
MDPI actively supports societies through the launch of new journals, the acquisition of established journals, and the transfer of society journals from other publishers. You can submit your proposal here.
Over the past 13 years, we have collaborated with over 190 learned societies and organizations. These partnerships range from affiliations with one or more of our journals to publishing journals on behalf of our partners.
Learn about how MDPI / Open Access Supports Societies.
In this section I highlight our Societies team, whose responsibilities include establishing new OA journals on behalf of societies and institutions, publishing an existing OA journal with MDPI or transitioning a subscription journal to an OA model, and establishing affiliations between societies and MDPI journals.
If you would like to learn more about these services, please see the Societies website.
The Societies team is led by Dr. Carla Aloè, Head of Societies and Acquisition, and her Deputy Manager, Dr. Clàudia Aunós. MDPI collaborates with a wide range of societies through various partnerships. For a complete list of collaborating societies and society journals, please visit the Societies website.
How long have you been at MDPI, and what was your first role?
I joined MDPI in September 2020 as an Associate Publisher and Scientific Officer, overseeing the Arts, Humanities, and Social Science journals. In July 2022, I took on the oversight of the Society and Acquisition team.
Do you think that perceptions of Open Access are generally accurate?
Far from it: there are in fact many misconceptions surrounding the way Open Access works and the benefits it has to offer. A common misconception is that OA journals are poor quality, which is entirely untrue. Many of our journals are included in major indexing databases, and all of them are endorsed by prominent associations and committees such as the Committee on Publication Ethics (COPE), the International Association of Scientific, Technical, and Medical Publishers (STM), and the Open Access Scholarly Publication Association (OASPA). We uphold a rigorous peer-review process, adhere to strict ethical standards, and rely on high-profile editorial boards.
How long have you been at MDPI, and what was your first role?
I’ve been at MDPI for almost seven years now. I started as an Assistant Editor but was quickly promoted to work with societies.
What is the most common question you get asked about the services that the Societies team provides?
For societies with a standard number of members (less than 500), the most common inquiry is about how much the publishing services we offer cost. One of the great things about our publishing services is that they are free of any burden cost to the society, regardless of the type of non-profit organization.
For bigger non-profit organizations, it is more about what benefits they can get for their members and ensuring that their journals are in good hands.
Either way, the goal is the same: to listen to the demands of the market, be flexible, and help our partners achieve healthy and positive development of their journals.
Read more:
Coming Together for Science
2024 MDPI Conference Summary
Throughout 2024, the MDPI Conference Team connected with scientific communities by organizing nine in-person events and 26 virtual conferences. In order to support the need for our growing events, we expanded this team to a total of 37 people across all offices, including 18 members in Asia-Pacific and 20 in the EU and North America.
The nine large-scale in-person conferences organized brought together leading minds across diverse disciplines, including our conferences on Viruses, Molecules, Polymers, Materials, Non-Coding RNA, Pharmaceuticals, and Sensors. These events strengthened synergies with the scientific community, actively promoting our journals and the latest research published within their respective fields. These achievements highlight our Conference Team’s dedication to creating meaningful and memorable events in the academic field.
2024 Event Highlights
Viruses 2024, the 5th edition of the conference series, hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes. The event attracted 240 attendees from around the globe. With 47 talks and nearly 130 poster presentations, the conference explored the latest developments in viral pathogenesis and immune responses across six engaging sessions.
Molecules 2024, the fourth edition of this conference series, highlighted the impact of emerging drug modalities on drug discovery. The event brought together over 100 attendees from 22 countries and featured more than 80 submissions organized into six sessions. The program included talks by 12 invited speakers from Europe, Asia and the United States. An impressive 97% of attendees rated the conference as ‘Excellent’ or ‘Good.’
Polymers 2024, attracted over 300 attendees from 22 countries and featured 259 accepted abstracts. Focusing on green polymer chemistry and the use of bioresources, the conference highlighted advancements in the synthesis of biobased and biodegradable polymers. Engaging lectures by three keynote speakers and 12 invited speakers, coupled with dynamic discussions, led 94% of attendees to rate the conference as ‘Excellent’ or ‘Good.’
A high-profile summit in Toronto was organized by the team, which expanded our global reach and showcased our capacity to deliver impactful events in our different offices. Sixteen EiC and seven EBMs joined our event, and with a 100% rate of Excellent/Good, over 90% of them said they are likely to attend our next edition.
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science successfully gathered about 400 participants onsite. Three hundred and fifty-five abstracts were accepted, with 772 authors from 28 countries. Across the four-day program, there were 296 talks delivered and 66 posters displayed.
The 2nd Sustainable Publishing Forum was successfully held in Beijing, China, with around 120 attendees from local publishers, editorial staff from local university presses, librarians, etc. The event is focused on promoting open science, maintaining research integrity and fulfilling social responsibility.
ICM 2024, the 5th International Conference on Materials, brought together scientists, researchers and industry leaders to explore advancements in materials characterization, processing and manufacturing. Topics ranged from nanotechnology and biomaterials to energy materials and AI-driven research. With 62 attendees from 26 different countries, the program featured 34 talks and 18 posters, fostering collaboration and innovation over 2.5 days.
The second edition of ncRNA 2024 welcomed 104 attendees from 30 countries, 71% of them being women. Two keynote speakers, Prof. Ling-Ling Chen and Prof. Mauro Giacca, shared insights drawn from over 10 years of experience. Prof. Giacca's groundbreaking work promises advances in curative therapies for heart failure, while Prof. Chen’s team continues to lead the development of the ncRNA field. High participant engagement generated valuable topics for future editions, and 96% of attendees rated the conference as ‘Excellent’ or ‘Good’.
Pharmaceuticals 2024, with its eight sessions, covered the newest technologies and the research areas of medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, among others. The conference featured three plenary and eight invited speakers, comprising esteemed scholars from eight different countries of Europe, and welcomed 64 participants from 28 different countries. Ninety-one percent of the attendees rated the conference as ‘Excellent’ or ‘Good’, highlighting the outstanding organzation of the event.
In 2024, we organized 26 virtual events with an average submission number of 158 abstracts per event, and an average registration number of 491 per event. Compared with the last edition, we saw a 42.2% growth of accepted abstract submissions.
The year 2024 marked a change in the strategy of our conference team, prioritizing the improvement of the communication and collaboration within our European and Asia-Pacific teams and creating stronger teamwork to elevate the quality and impact of MDPI events.
Scheduled Events in 2025
- Smart Sustainable Cities 2025: Pioneering Novel Frontiers for Green Urban Living: 5–7 Mar 2025, online.
- International Conference on Advanced Remote Sensing (ICARS 2025): 26–28 Mar 2025, Barcelona, Spain.
- Plants 2025: From Seeds to Food Security: 31 Mar–2 Apr 2025, Barcelona, Spain.
- Symmetry 2025 - The 5th International Conference on Symmetry: 16–19 May 2025, Hangzhou, China.
- The 2nd International Conference on AI Sensors and Transducers: 29 Jul–3 Aug 2025, Bangkok, Thailand.
- The 5th International Symposium on Frontiers in Molecular Science: 26–29 Aug 2025, Kyoto, Japan.
- The 11th World Sustainability Forum: Sustainable and Resilient Cities: 2–3 Oct 2025, Barcelona, Spain.
- The Cancers 2025 and Sensors 2025 websites will soon be made public.
Closing Thoughts
Over 100 German Universities Partner with MDPI in New National Agreement
I am pleased to share some exciting end-of-year news: MDPI has reached a major milestone by signing a publishing agreement with over 100 German universities and research institutions! Negotiated by ZB MED - Informationszentrum Lebenswissenschaften, the agreement came into effect on 1 January 2025 and will run until the end of 2026.
This new cooperation aims to make scientific Gold Open Access publishing more affordable and less administratively burdensome for researchers in Germany.
Learn more, here.
“Thank you to everyone who contributed to making this agreement a reality.”
Why is this important?
Germany is a global leader in academic research and publishing, ranking fifth in total MDPI publication volume.
This agreement reflects our growing influence and leadership in open access publishing.
Partnering with more than 100 institutions highlights MDPI’s reputation as a trusted publishing partner for the academic community.
As Peter Roth, MDPI Head of Publishing, noted:
“MDPI can look back on over a decade of successful partnerships with German research institutions. This agreement marks another milestone in our collaboration with the German scientific community.”
Adrian Stefan Zamfir, Institutional Partnership Manager for the DACH region, added:
“We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform”
Thank you to everyone who contributed to making this agreement a reality. This milestone reinforces MDPI as a trusted leader in advancing open access and supporting researchers worldwide.
Chief Executive Officer
MDPI AG
7 January 2025
Journal of Clinical Medicine | Notable Papers in Q4 of 2024
